HCD Economics, Daresbury, UK.
Faculty of Health and Social Care, University of Chester, Chester, UK.
Haemophilia. 2020 Jul;26(4):711-717. doi: 10.1111/hae.13985. Epub 2020 Apr 8.
The benefits of physical activity (PA) for people with haemophilia (PWH) may include improvements in joint, bone and muscle health. However, the factor VIII activity level required to avoid a bleeding episode associated with PA is unknown.
To elicit the opinion of clinical experts on the minimum level and ideal factor VIII activity ('level') required to avoid a bleeding episode during participation in different types of PA for PWH.
Based on the 2017 National Hemophilia Foundation PA descriptions, clinical experts estimated a minimally acceptable and an ideal factor level at which a bleed could be avoided. The uncertainty around estimates was quantified using an approach to construct a probability distribution to represent expert opinion.
Minimum and ideal factor level increased with higher risk PA, whether or not joint morbidity was present, as did the experts' uncertainty in their estimates (ie the range between lowest and highest estimates for minimum and ideal levels). Mean minimum levels ranged from 4% to 48% for low to high risk for people without joint morbidity, and from 7% to 47% for those with joint morbidity. For ideal factor levels, corresponding figures were 9%-52% and 12%-64%, respectively.
To support a patient-centric outcome, expert opinion indicates that the clinical norm of 0.01 IU/mL (1%) trough level is insufficient. It is anticipated that introducing a more targeted approach to meet the needs of patients who are increasingly physically active will benefit patients further in addition to recent treatment advances.
身体活动(PA)对血友病患者(PWH)可能有益,包括改善关节、骨骼和肌肉健康。然而,避免与 PA 相关的出血事件所需的因子 VIII 活性水平尚不清楚。
征求临床专家对 PWH 参与不同类型 PA 时避免出血事件所需的最低因子 VIII 活性(“水平”)和理想因子 VIII 活性的意见。
基于 2017 年国家血友病基金会 PA 描述,临床专家估计了在避免出血的情况下可接受的最低因子水平和理想因子水平。使用一种构建概率分布的方法来量化估计值的不确定性,以代表专家意见。
无论是否存在关节疾病,较高风险的 PA 所需的最小和理想因子水平以及专家对其估计的不确定性(即最低和最高估计值之间的范围)均会增加。对于没有关节疾病的人,从低风险到高风险的最小因子水平范围从 4%到 48%,对于有关节疾病的人,最小因子水平范围从 7%到 47%。对于理想因子水平,相应的数字分别为 9%-52%和 12%-64%。
为了支持以患者为中心的结果,专家意见表明,0.01 IU/mL(1%)的最低水平不足以满足临床需要。预计引入更有针对性的方法来满足越来越活跃的患者的需求,除了最近的治疗进展外,还将使患者进一步受益。